The neurochemical consequences of methamphetamine self-administration in male and female rats.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28645061.
- Also identified by DOI 10.1016/j.drugalcdep.2017.04.011 and PMC identifier 5597241.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Methamphetamine (METH) is an addictive substance that is used in both males and females. Few preclinical studies have focused on understanding sex-differences in the neurochemical consequences of contingent METH. The purpose of the current study was to investigate potential sex-differences in the neurochemical consequences of METH self-administration. Male and female adult rats were given extended access to METH or saline self-administration for 7d. Following self-administration, hippocampal brain-derived neurotrophic factor (BDNF) and striatal dopamine transporter (DAT) were assessed via western blotting. Male and female rats had similar METH intake. METH self-administration reduced striatal DAT in both sexes, but only males that self-administered METH had elevated hippocampal BDNF levels. Sex-differences exist in the neurochemical consequences of METH self-administration. These differences may lead to sex-specific vulnerability to the toxic effects of METH.
Medical subject headings
- Brain-Derived Neurotrophic Factor
- Corpus Striatum
- Dopamine Plasma Membrane Transport Proteins
- Hippocampus
- Methamphetamine
- Substance-Related Disorders